Straumann Holding AG (SAUHF)
147.35
-9.99
(-6.35%)
USD |
OTCM |
Apr 24, 16:00
Straumann Total Return Price: 147.35 for April 24, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 23, 2024 | 157.34 |
| April 22, 2024 | 144.38 |
| April 19, 2024 | 145.65 |
| April 18, 2024 | 142.30 |
| April 17, 2024 | 150.00 |
| April 16, 2024 | 144.74 |
| April 15, 2024 | 148.23 |
| April 12, 2024 | 150.56 |
| April 11, 2024 | 154.18 |
| April 10, 2024 | 151.08 |
| April 09, 2024 | 156.66 |
| April 08, 2024 | 148.03 |
| April 05, 2024 | 150.39 |
| April 04, 2024 | 151.61 |
| April 03, 2024 | 149.62 |
| April 02, 2024 | 154.23 |
| April 01, 2024 | 152.94 |
| March 28, 2024 | 159.84 |
| March 27, 2024 | 158.16 |
| March 26, 2024 | 155.62 |
| March 25, 2024 | 153.44 |
| March 22, 2024 | 156.32 |
| March 21, 2024 | 162.58 |
| March 20, 2024 | 155.71 |
| March 19, 2024 | 160.64 |
| Date | Value |
|---|---|
| March 18, 2024 | 155.99 |
| March 15, 2024 | 160.12 |
| March 14, 2024 | 164.94 |
| March 13, 2024 | 166.16 |
| March 12, 2024 | 163.77 |
| March 11, 2024 | 164.32 |
| March 08, 2024 | 169.43 |
| March 07, 2024 | 167.84 |
| March 06, 2024 | 165.66 |
| March 05, 2024 | 160.09 |
| March 04, 2024 | 160.69 |
| March 01, 2024 | 159.74 |
| February 29, 2024 | 157.86 |
| February 28, 2024 | 160.14 |
| February 27, 2024 | 165.81 |
| February 26, 2024 | 165.11 |
| February 23, 2024 | 163.02 |
| February 22, 2024 | 163.87 |
| February 21, 2024 | 159.82 |
| February 20, 2024 | 163.07 |
| February 16, 2024 | 161.09 |
| February 15, 2024 | 162.57 |
| February 14, 2024 | 153.53 |
| February 13, 2024 | 155.22 |
| February 12, 2024 | 160.17 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
56.51
Minimum
Mar 19 2020
223.98
Maximum
Nov 09 2021
126.13
Average
121.61
Median
Mar 22 2021
Total Return Price Benchmarks
| AC Immune SA | 2.36 |
| CRISPR Therapeutics AG | 55.61 |
| Addex Therapeutics Ltd | 15.91 |
| NLS Pharmaceutics Ltd | 0.1275 |
| Molecular Partners AG | 3.70 |